Impact of DSM-5 Revisions and the COVID-19 Pandemic on ADHD Diagnosis Trends in Individuals Under 30 - Takeaways - MDSpire

Impact of DSM-5 Revisions and the COVID-19 Pandemic on ADHD Diagnosis Trends in Individuals Under 30

  • By

  • Zishan Cui

  • Anshula Ambasta

  • Wade Thompson

  • Ken Bassett

  • Greg Carney

  • Colin Dormuth

  • April 8, 2026

  • 0 min

Share

  • 1

    ADHD diagnoses in British Columbia increased significantly over two decades, particularly after DSM-5 implementation and the COVID-19 pandemic.

  • 2

    The incidence of ADHD diagnoses accelerated among elementary school-aged children, especially males and females, following DSM-5 changes.

  • 3

    Post-COVID-19, the highest incidence increases were observed among high school-aged female adolescents and young adults.

  • 4

    The revisions in DSM-5 may have broadened diagnostic criteria, increasing ADHD recognition and help-seeking behaviors.

  • 5

    The study highlights the need for ongoing monitoring of ADHD diagnostic trends, particularly among females, to ensure adequate assessment and services.

Original Source(s)

Impact of DSM-5 Revisions and the COVID-19 Pandemic on ADHD Diagnosis Trends in Individuals Under 30

  • by Zishan Cui, Anshula Ambasta, Wade Thompson, Ken Bassett, Greg Carney, Colin Dormuth

  • April 8, 2026

Related Content

Downstream Healthcare Use Associated with Primary Care In-Person and Telemedicine Visits in 2022

Patient-Reported Outcomes of Nirmatrelvir Treatment for High-Risk, Nonhospitalized Adults With Symptomatic COVID-19

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.